Balaxi Pharmaceuticals

quarterly
yearly
ParticularsMar '23Jun '23Sep '23Dec '23Mar '24
Revenue30.5325.1717.7013.7316.06
Expenses25.4521.6616.1312.9616.33
EBITDA5.583.902.061.310.37
EBIT5.323.771.931.180.25
Profit Before Tax5.083.501.570.77-0.27
Net Profit3.942.551.180.49-0.58
Financial Ratios
Operating Profit Margin18.39%15.58%12.51%10.31%2.26%
Net Profit Margin12.98%10.18%7.13%3.86%-3.65%
Earning Per Share (Diluted)3.832.471.150.47-0.55
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.1.2
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ